Aller au menu Aller au contenu

Mutual GMDP Inspections Recognition Agreement will come into force from the 1st of November 2017

A mutual agreement has been reached between the USA and Europe regarding the Inspections of medicine manufacturing sites (GMDP). This agreement will allow for any inspections carried out on either side of the Atlantic to be recognized legally. It also encourages rationalisation worldwide. Therefore, permitting more inspections to be carried out elsewhere in the world where medicine is produced. The FDA and the European Commission have placed France in the first wave of countries which is due to take place in 2017.